Literature DB >> 7266270

Inhibition of hepatic cholesterol biosynthesis by chloroquine.

A C Beynen, A J van der Molen, M J Geelen.   

Abstract

Chloroquine is shown to be a potent inhibitor of cholesterol biosynthesis by isolated rat hepatocytes. Half-maximal inhibition of cholesterogenesis occurs at ca. 10 micro M chloroquine. Chloroquine does not affect fatty acid synthesis by isolated hepatocytes. This suggests that chloroquine acts on the cholesterol biosynthetic pathway beyond the cytosolic acetyl-coA branchpoint of cholesterol and fatty acid synthesis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7266270     DOI: 10.1007/BF02535017

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  8 in total

1.  Studies on the inhibition of hepatic lipogenesis by N-6,O-2'-dibutyryl adenosine 3',5'-monophosphate.

Authors:  R A Harris
Journal:  Arch Biochem Biophys       Date:  1975-07       Impact factor: 4.013

Review 2.  Preparation of isolated rat liver cells.

Authors:  P O Seglen
Journal:  Methods Cell Biol       Date:  1976       Impact factor: 1.441

3.  Lysosomal triacylglycerol lipase and lipolysis in isolated rat hepatocytes.

Authors:  L J Debeer; J Thomas; P J De Schepper; G P Mannaerts
Journal:  J Biol Chem       Date:  1979-09-25       Impact factor: 5.157

Review 4.  Compartmentation of the early steps of cholesterol biosynthesis in mammalian liver.

Authors:  K Decker; C Barth
Journal:  Mol Cell Biochem       Date:  1973-12-15       Impact factor: 3.396

5.  3- -Hydroxysterol synthesis by the liver.

Authors:  H Brunengraber; J R Sabine; M Boutry; J M Lowenstein
Journal:  Arch Biochem Biophys       Date:  1972-06       Impact factor: 4.013

6.  Inhibition of hepatocyte proteolysis and lactate gluconeogenesis by chloroquine.

Authors:  D W Crabb; R A Jersild; S A McCune; M S Swartzentruber; R A Harris
Journal:  Arch Biochem Biophys       Date:  1980-08       Impact factor: 4.013

7.  Comparison of the effects of clofibrate and halofenate (MK-185) in isolated rat hepatocytes.

Authors:  C J Homcy; S Margolis
Journal:  Atherosclerosis       Date:  1974 May-Jun       Impact factor: 5.162

8.  Opposite effects of insulin and glucagon in acute hormonal control of hepatic lipogenesis.

Authors:  A C Beynen; W J Vaartjes; M J Geelen
Journal:  Diabetes       Date:  1979-09       Impact factor: 9.461

  8 in total
  7 in total

Review 1.  A favorable effect of hydroxychloroquine on glucose and lipid metabolism beyond its anti-inflammatory role.

Authors:  Mirella P Hage; Marwa R Al-Badri; Sami T Azar
Journal:  Ther Adv Endocrinol Metab       Date:  2014-08       Impact factor: 3.565

2.  Use of Hydroxychloroquine Is Associated With Improved Lipid Profile in Rheumatoid Arthritis Patients.

Authors:  Jose Felix Restrepo; Inmaculada Del Rincon; Emily Molina; Daniel F Battafarano; Agustin Escalante
Journal:  J Clin Rheumatol       Date:  2017-04       Impact factor: 3.517

3.  Polymorphism of the beta3-adrenergic receptor and lipid profile in patients with rheumatoid arthritis and systemic lupus erythematosus treated with chloroquine.

Authors:  J F Muñoz-Valle; M Vázquez-Del Mercado; S Ruiz-Quezada; E Oregón-Romero; R E Navarro-Hernández; J Ramírez-Barragán; G Martínez-Bonilla; G Bernard-Medina; B E Bastidas-Ramírez; B Ruiz-Madrigal; A Panduro
Journal:  Rheumatol Int       Date:  2003-03-12       Impact factor: 2.631

4.  Association of Triple Therapy With Improvement in Cholesterol Profiles Over Two-Year Followup in the Treatment of Early Aggressive Rheumatoid Arthritis Trial.

Authors:  Christina Charles-Schoeman; Xiaoyan Wang; Yuen Yin Lee; Ani Shahbazian; Iris Navarro-Millán; Shuo Yang; Lang Chen; Stacey S Cofield; Larry W Moreland; James O'Dell; Joan M Bathon; Harold Paulus; S Louis Bridges; Jeffrey R Curtis
Journal:  Arthritis Rheumatol       Date:  2016-03       Impact factor: 10.995

5.  Disease-modifying antirheumatic drug use and the risk of incident hyperlipidemia in patients with early rheumatoid arthritis: a retrospective cohort study.

Authors:  Rishi J Desai; Wesley Eddings; Katherine P Liao; Daniel H Solomon; Seoyoung C Kim
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-04       Impact factor: 4.794

Review 6.  Lipid Metabolism: Immune Regulation and Therapeutic Prospectives in Systemic Lupus Erythematosus.

Authors:  Wei Sun; Pengchong Li; Jianping Cai; Jie Ma; Xuan Zhang; Yong Song; Yudong Liu
Journal:  Front Immunol       Date:  2022-03-18       Impact factor: 7.561

Review 7.  DMARDs-Gut Microbiota Feedback: Implications in the Response to Therapy.

Authors:  Oscar Zaragoza-García; Natividad Castro-Alarcón; Gloria Pérez-Rubio; Iris Paola Guzmán-Guzmán
Journal:  Biomolecules       Date:  2020-10-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.